Related Experiment Video
Updated: Feb 14, 2026
08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
5.7K
Paediatric Therapeutic Development Workshop on rhabdoid tumours
Claudia Montiel Equihua1, Jan J Molenaar2, Itziar Areso1
1LifeArc, London, UK.
British Journal of Cancer
|February 12, 2026
Summary
Rhabdoid tumours (RT) are aggressive childhood cancers. Research identified DDB1-CUL4-associated factor 5, EZH2, and MDM2 as priority targets for developing new, less toxic therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pediatric Cancer Research
Background:
- Rhabdoid tumours (RT) are aggressive pediatric malignancies affecting the central nervous system, kidneys, liver, and soft tissues.
- Current treatments (surgery, chemotherapy, radiotherapy) have low survival rates (<30%) and significant toxicities.
- There is a critical need for targeted therapies to improve outcomes and reduce treatment-related harm in RT.
Purpose of the Study:
- To identify and prioritize therapeutic targets for rhabdoid tumours (RT).
- To guide the development of novel, targeted therapeutics with improved efficacy and reduced toxicity.
- To establish a unified therapeutic strategy for both intra-cranial and extra-cranial RT, based on shared SMARCB1/SMARCA4 biology.
Main Methods:
- Comprehensive research review and expert workshop.
- Identification of key molecular targets based on RT biology (SMARCB1/SMARCA4 inactivation).
- Evaluation of potential therapeutic strategies including small molecule binders/degraders and inhibitors.
Main Results:
- DDB1-CUL4-associated factor 5 identified as a priority target for small molecule development.
- Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) degraders show potential over inhibitors.
- Mouse double minute 2 homolog (MDM2) is a priority target, with combination therapies (EZH2, MDM2 inhibitors, selective nuclear export inhibitors) recommended for preclinical and clinical evaluation.
Conclusions:
- Targeted therapies are crucial for improving outcomes in rhabdoid tumours.
- Specific molecular targets (DDB1-CUL4-associated factor 5, EZH2, MDM2) offer promising avenues for drug development.
- Preclinical and clinical studies of combination therapies are essential to advance treatment for RT.
Related Concept Videos
01:13Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
01:30Therapeutic Communication
8.7K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.7K
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
01:30Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.0K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.0K